SGLT2 Inhibitor Use Not Tied to Increased Fracture Risk in CKD

WEDNESDAY, June 1, 2022 (HealthDay News) -- For older adults, initiation of a sodium-glucose cotransporter-2 (SGLT2) inhibitor is not associated with higher fracture risk compared with initiation of a dipeptidyl

Related Keywords

United States ,Canada ,London ,City Of ,United Kingdom ,American ,Andrea Cowan ,Evaluative Sciences ,Institute For Clinical ,Healthday News ,Clinical Journal ,American Society , ,